𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic haloperidol administration increases the density of D2 dopamine receptors in the medial prefrontal cortex of the rat

✍ Scribed by A. John MacLennan; Stella Atmadja; Nancy Lee; H. C. Fibiger


Publisher
Springer
Year
1988
Tongue
English
Weight
299 KB
Volume
95
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

✦ Synopsis


Rats received haloperidol (1.3-1.5 mg/kg/day) via their drinking water for 21 weeks. At the end of this period the density of D2 dopamine receptors and their affinity for [3H]-spiperone were measured in the striatum and medial prefrontal cortex. The chronic haloperidol treatment increased the density of D2 receptors in the striatum by 70% and in the medial prefrontal cortex by 50%. The chronic haloperidol did not significantly alter the apparent affinity of D2 receptors for [3H]-spiperone in either structure. These results indicate that the density of D2 receptors in the medial prefrontal cortex is influenced by chronic exposure to haloperidol in a manner that is very similar to the welt-documented increase that occurs in the striarum.


πŸ“œ SIMILAR VOLUMES


Catalepsy after microinjection of halope
✍ T. Klockgether; M. Schwarz; L. Turski; K.-H. Sontag πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag 🌐 English βš– 282 KB

To investigate the behavioural role of mesocortical dopamine innervation we performed bilateral microinjections of haloperidol into various parts of the rat frontal cortex and into adjacent subcortical forebrain structures. Haloperidol (2.5 micrograms/0.5 microliter) locally injected into the medial

Local infusion of the serotonin antagoni
✍ Elizabeth A. Pehek πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 876 KB

Previous research has indicated that atypical antipsychotic drugs like clozapine preferentially increase dopamine (DA) release from the mesocortical, relative to the nigrostriatal, system. While these drugs generally have weak affinity for the D2 receptor subtype, they are potent antagonists of the

Blockade of D-1 dopamine receptors in th
✍ Paul Vezina; GΓ©rard Blanc; Jacques Glowinski; Jean-Pol Tassin πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 998 KB

The present experiments assessed the acute and delayed effects of D-1 dopamine (DA) receptor blockade in the medial prefrontal cortex (mPFC) on pre-and postsynaptic indices of DA neurotransmission in the nucleus accumbens (N.Acc). Different groups of rats received intra-mPFC injections of saline (co

Blockade of tachykinin NK1 receptors att
✍ Giuliano Renoldi; Roberto W. Invernizzi πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 309 KB πŸ‘ 1 views

## Abstract Substance P receptor antagonists cause antidepressant‐ and anxiolytic‐like effects in rodents that are thought to involve brain monoamines. In the present study, we examined the effects of the NK1 receptor antagonist GR‐205,171 on basal and stress‐induced rise of extracellular noradrena

Ξ±-noradrenergic receptor modulation of t
✍ J. David Jentsch; Alyssa Wise; Zachary Katz; Robert H. Roth πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 75 KB

The noncompetitive NMDA receptor antagonist phencyclidine (PCP) and the neuronal cannabinoid receptor agonist ⌬ 9 -tetrahydrocannabinol (THC) are two agents shown to have psychotomimetic properties in humans. Both drugs increase dopamine release and utilization in the prefrontal cortex, a brain regi